What are "Rare Diseases"?

Rare Diseases are medical conditions that affect a very small number of individuals globally, often making diagnosis difficult and treatment options limited. With over 7,000 identified rare diseases worldwide, ensuring patient access to appropriate therapy remains one of the most critical challenges on the front lines of modern medicine.

Social Challenges & Orphan Drugs

The Diagnostic Odyssey:
Due to a lack of specialists and clinical cases, patients often face a 'diagnostic maze,' taking years to receive an accurate diagnosis. The development and distribution of Orphan Drugs (medications for rare diseases) are urgent global priorities.

Geographical Access Gaps (Drug Lag):
Effective treatments approved in one country may remain unapproved or unavailable in others, leading to a loss of life critical treatment opportunities.

Expectations for Japanese Pharmaceuticals:
High-quality rare disease medications approved under Japan's rigorous regulatory standards represent a vital lifeline for patients and physicians worldwide.

Social Mission of synapse

• 'synapse' is dedicated to breaking down the 'information barriers' and 'logistical walls' in rare disease treatment.

• Globalization of Information:
  By publishing data on Japanese-approved orphan drugs in English, we empower global specialists to conduct rapid, accurate research.

• Supporting the Last Mile:
  We provide overseas medical institutions with a streamlined procurement route via 'My List' and the RFQ process. Our platform supports Expanded Access (Compassionate Use), ensuring that life-saving medicines reach the patients who need them most from a humanitarian perspective.